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To determine whether medRxiv data availability statements describe open or closed data—
that is, whether the data used in the study is openly available without restriction—and to
examine if this changes on publication based on journal data-sharing policy. Additionally, to
examine whether data availability statements are sufficient to capture code availability
declarations.
Design
Observational study, following a pre-registered protocol, of preprints posted on the medRxiv
repository between 25th June 2019 and 1st May 2020 and their published counterparts.
Main outcome measures
Distribution of preprinted data availability statements across nine categories, determined by
a prespecified classification system. Change in the percentage of data availability state-
ments describing open data between the preprinted and published versions of the same
record, stratified by journal sharing policy. Number of code availability declarations reported
in the full-text preprint which were not captured in the corresponding data availability
statement.
Results
3938 medRxiv preprints with an applicable data availability statement were included in our
sample, of which 911 (23.1%) were categorized as describing open data. 379 (9.6%) pre-
prints were subsequently published, and of these published articles, only 155 contained an
applicable data availability statement. Similar to the preprint stage, a minority (59 (38.1%))
of these published data availability statements described open data. Of the 151 records eli-
gible for the comparison between preprinted and published stages, 57 (37.7%) were
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published in journals which mandated open data sharing. Data availability statements more
frequently described open data on publication when the journal mandated data sharing
(open at preprint: 33.3%, open at publication: 61.4%) compared to when the journal did not
mandate data sharing (open at preprint: 20.2%, open at publication: 22.3%).
Conclusion
Requiring that authors submit a data availability statement is a good first step, but is insuffi-
cient to ensure data availability. Strict editorial policies that mandate data sharing (where
appropriate) as a condition of publication appear to be effective in making research data
available. We would strongly encourage all journal editors to examine whether their data
availability policies are sufficiently stringent and consistently enforced.
1 Introduction
The sharing of data generated by a study is becoming an increasingly important aspect of sci-
entific research [1, 2]. Without access to the data, it is harder for other researchers to examine,
verify and build on the results of that study [3]. As a result, many journals now mandate data
availability statements. These are dedicated sections of research articles, which are intended to
provide readers with important information about whether the data described by the study are
available and if so, where they can be obtained [4].
While requiring data availability statements is an admirable first step for journals to take,
and as such is viewed favorably by journal evaluation rubrics such as the Transparency and
Openness Promotion [TOP] Guidelines [5], a lack of review of the contents of these statements
often leads to issues. Many authors claim that their data can be made “available on request”,
despite previous work establishing that these statements are demonstrably untrue in the
majority of cases—that when data is requested, it is not actually made available [6–8]. Addi-
tionally, previous work found that the availability of data “available on request” declines with
article age, indicating that this approach is not a valid long term option for data sharing [9].
This suggests that requiring data availability statements without a corresponding editorial or
peer review of their contents, in line with a strictly enforced data-sharing policy, does not
achieve the intended aim of making research data more openly available. However, few jour-
nals actually mandate data sharing as a condition of publication. Of a sample of 318 biomedical
journals, only ~20% had a data-sharing policy that mandated data sharing [10].
Several previous studies have examined the data availability statements of published articles
[4, 11–13], but to date, none have examined the statements accompanying preprinted manu-
scripts, including those hosted on medRxiv, the preprint repository for manuscripts in the
medical, clinical, and related health sciences [14]. Given that preprints, particularly those on
medRxiv, have impacted the academic discourse around the recent (and ongoing) COVID-19
pandemic to a similar, if not greater, extent than published manuscripts [15], assessing
whether these studies make their underlying data available without restriction (i.e. “open”),
and adequately describe how to access it in their data availability statements, is worthwhile. In
addition, by comparing the preprint and published versions of the data availability statements
for the same paper, the potential impact of different journal data-sharing policies on data avail-
ability can be examined. This study aimed to explore the distribution of data availability state-
ments’ description of the underlying data across a number of categories of “openness” and to
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assess the change between preprint and journal-published data availability statements, strati-
fied by journal data-sharing policy. We also intended to examine whether authors planning to
make the data available upon publication actually do so, and whether data availability state-
ments are sufficient to capture code availability declarations.
2 Methods
2.1 Protocol and ethics
A protocol for this analysis was registered in advance and followed at all stages of the study
[16]. Any deviations from the protocol are described. Ethical approval was not required for
this study.
2.2 Data extraction
The data availability statements of preprints posted on the medRxiv preprint repository
between 25th June 2019 (the date of first publication of a preprint on medRxiv) and 1st May
2020 were extracted using the medrxivr and rvest R packages [17, 18]. Completing a data avail-
ability statement is required as part of the medRxiv submission process, and so a statement
was available for all eligible preprints. Information on the journal in which preprints were sub-
sequently published was extracted using the published DOI provided by medRxiv and rcross-
ref [19]. Several other R packages were used for data cleaning and analysis [20–33].
To extract the data availability statements for published articles and the journals data-shar-
ing policies, we browsed to the article or publication website and manually copied the relevant
material (where available) into an Excel file. The extracted data are available for inspection (see
Material availability section).
2.3 Categorization
A pre-specified classification system was developed to categorize each data availability state-
ment as describing either open or closed data, with additional ordered sub-categories indicat-
ing the degree of openness (see Table 1). The system was based on the “Findability” and
“Accessibility” elements of the FAIR framework [34], the categories used by previous effort to
categorize published data availability statements [4, 11], our own experience of medRxiv data
availability statements, and discussion with colleagues. Illustrative examples of each category
were taken from preprints included in our sample [35–43].
The data availability statement for each preprinted record were categorized by two indepen-
dent researchers, using the groups presented in Table 1, while the statements for published
articles were categorized using all groups barring Category 3 and 4 (“Available in the future”).
Records for which the data availability statement was categorized as “Not applicable” (Cate-
gory 1 from Table 1) at either the preprint or published stage were excluded from further anal-
yses. Researchers were provided only with the data availability statement, and as a result, were
blind to the associated preprint metadata (e.g. title, authors, corresponding author institution)
in case this could affect their assessments. Any disagreements were resolved through
discussion.
Due to our large sample, if authors claimed that all data were available in the manuscript or
as a S1 File, or that their study did not make use of any data, we took them at their word.
Where a data availability statement met multiple categories or contained multiple data sources
with varying levels of openness, we took a conservative approach and categorized it on the
basis of the most restrictive aspect (see S1 File for some illustrative examples). We plotted the
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distribution of preprint and published data availability statements across the nine categories
presented in Table 1.
Similarly, the extracted data-sharing policies were classified by two independent reviewers
according to whether the journal mandated data sharing (1) or not (0). Where the journal had
no obvious data sharing policy, these were classified as not mandating data sharing.
2.4 Changes between preprinted and published statements
To assess if data availability statements change between preprint and published articles, we
examined whether a discrepancy existed between the categories assigned to the preprinted and
published statements, and the direction of the discrepancy (“more closed” or “more open”).
Records were deemed to become “more open” if their data availability statement was catego-
rized as “closed” at the preprint stage and “open” at the published stage. Conversely, records
described as “more closed” were those moving from “open” at preprint to “closed” on
publication.
We declare a minor deviation from our protocol for this analysis [16]. Rather than investi-
gating the data-sharing policy only for journals with the largest change in openness as
intended, which involved setting an arbitrary cut-off when defining “largest change”, we sys-
tematically extracted and categorized the data-sharing policies for all journals in which pre-
prints had subsequently been published using two categories (1: “requiring/mandating data
sharing” and, 2: “not requiring/mandating data sharing”), and compared the change in open-
ness between these two categories. Note that Category 2 includes journals that encourage data
sharing, but do not make it a condition of publication.
Table 1. Categories used to classify the data availability statements.
Key Main category Sub-category Example
0 Not applicable (protocol for
a review, commentary, etc)
"Data sharing not applicable to this article as no datasets were
generated or analysed during the current study." [35]
1 "Closed" Data not made available "Not available for public" [36]
2 "Closed" Data available on request to authors "Data can be available upon reasonable request to the
corresponding author." [37]
3 "Closed" Data will be made available in the future (link provided) "The protocol and full dataset will be available at Open Science
Framework upon peer review publication (https://osf.io/rvbuy/)."
[38]
4 "Closed" Data will be made available in the future (no link provided) "Data will be deposited in Dryad upon publication" [39]
5 "Closed" Data available from central repository (access-controlled or
open access), but insufficient detail available to find specific
dataset
"Data were obtained from the international MSBase cohort study.
Information regarding data availability can be obtained at https://
www.msbase.org/." OR Daily diagnosis number of countries




6 "Closed" Data available from central access-controlled repository, and
sufficient details included to identify specific dataset e.g. via
extract or accession ID or date stamp
"This research has been conducted using the UK Biobank
Resource under application number 24494. All bona fide
researchers can apply to use the UK Biobank resource for health
related research that is in the public interest." [41]
7 "Open" Data available in the manuscript/S1 File "All data related to this study are present in the paper or the S1
File." [42]
8 "Open" Data available via a online repository that is not access-
controlled e.g. Dryad, Zenodo
"Extracted data used in this meta-analysis and analysis code are
available at www.doi.org/10.5281/zenodo.3149365." [43]
Illustrative examples of each category were taken from preprints included in our sample (see "Data extraction").
https://doi.org/10.1371/journal.pone.0250887.t001
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To assess claims that data will be provided on publication, the data availability statements
accompanying the published articles for all records in Category 3 (“Data available on publica-
tion (link provided)”) or Category 4 (“Data available on publication (no link provided)”) from
Table 1 were assessed, and any difference between the two categories examined.
2.5 Code availability
Finally, to assess whether data availability statements also capture the availability of program-
ming code, such as STATA do files or R scripts, the data availability statement and full text
PDF for a random sample of 400 preprinted records were assessed for code availability (1:
“code availability described” and 2: “code availability not described”).
3 Results
The data availability statements accompanying 4101 preprints registered between 25th June
2019 and 1st May 2020 were extracted from the medRxiv preprint repository on the 26th May
2020 and were coded by two independent researchers according to the categories in Table 1.
During this process, agreement between the raters was high (Cohen’s Kappa = 0.98; “almost
perfect agreement”) [44].
Of the 4101 preprints, 163 (4.0%) in Category 0 (“Not applicable”) were excluded following
coding, leaving 3938 remaining records. Of these, 911 (23.1%) had made their data open as per
the criteria in Table 1. The distribution of data availability statements across the categories can
be seen in Fig 1. A total of 379 (9.6%) preprints had been subsequently published, and of these,
only 159 (42.0%) had data availability statements that we could categorize. 4 (2.5%) records in
Fig 1. Distribution of the data availability statements of preprinted (Panel A) and published (Panel B) records by
category from Table 1.
https://doi.org/10.1371/journal.pone.0250887.g001
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Category 0 (“Not applicable”) were excluded, and of the 155 remaining, 59 (38.1%) had made
their data open as per our criteria.
For the comparison of preprinted data availability statements with their published counter-
parts, we excluded records that were not published, that did not have a published data avail-
ability statement or that were labeled as “Not applicable” at either the preprint or published
stage, leaving 151 records (3.7% of the total sample of 4101 records) records.
Data availability statements more frequently described open data on publication compared
to the preprinted record when the journal mandated data sharing (Table 2). Moreover, the
data availability statements for 8 articles published in journals that did not mandate open data
sharing became less open on publication. The change in openness for preprints grouped by
category and stratified by journal policy is shown in S1 Table in S1 File, while the change for
each individual journal included in our analysis is shown in S2 Table in S1 File.
Interestingly, 22 records published in a journal mandating open data sharing did not have
an open data availability statement. The majority of these records described data that was avail-
able from a central access-controlled repository (Category 5 or 6), while in others, legal restric-
tions were cited as the reason for lack of data sharing. However, in some cases, data was either
insufficiently described or was only available on request (S3 Table in S1 File), indicating that
journal policies which mandate data sharing may not always be consistently applied allowing
some records may slip through the gaps.
161 (4.1%) preprints stated that data would be available on publication, but only 10 of these
had subsequently been published (Table 3) and the number describing open data on publica-
tion did not seem to vary based on whether the preprinted data availability statements include
a link to an embargoed repository or not, though the sample size is small.
Of the 400 records for which code availability was assessed, 75 mentioned code availability
in the preprinted full-text manuscript. However, only 22 (29.3%) of these also described code
availability in the corresponding data availability statement (S4 Table in S1 File).





Open DAS in preprinted
version % (N)
Open DAS in published
version % (N)










94 20.2% (19) 22.3% (21) 10 8 76
Mandates open data 57 33.3% (19) 61.4% (35) 16 0 41
https://doi.org/10.1371/journal.pone.0250887.t002
Table 3. Assessment of whether researchers promising to make data available on publication actually do so, and whether this differs if researchers included a link
to an embargoed repository or not.
Preprint Category Number of
preprints
Published Category Number of
published studies
Data available in the future, with a link to an
embargoed repository provided
3 1. Data not made available 1 (33.3%)
5. Data available from central repository (access-controlled or open
access), but insufficient detail available to find specific dataset
1 (33.3%)
8. Data available via a online repository that is not access-controlled e.g.
Dryad, Zenodo
1 (33.3%)
Data available in the future, with no details of
embargoed repository given
7 1. Data not made available 1 (14.3%)
2. Data available on request to authors 1 (14.3%)
7. Data available in the manuscript/S1 File 1 (14.3%)
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4 Discussion
4.1 Principal findings and comparison with other studies
We have reviewed 4101 preprinted and 159 published data availability statements, coding
them as “open” or “closed” according to a predefined classification system. During this labor-
intensive process, we appreciated statements that reflected the authors’ enthusiasm for data
sharing (“YES”) [45], their bluntness (“Data is not available on request.”) [46], and their efforts
to endear themselves to the reader (“I promise all data referred to in the manuscript are avail-
able.”) [47]. Of the preprinted statements, almost three-quarters were categorized as “closed”,
with the largest individual category being “available on request”. In light of the substantial
impact that studies published as preprints on medRxiv have had on real-time decision making
during the current COVID-19 pandemic [15], it is concerning that data for these preprints is
so infrequently readily available for inspection.
A minority of published records we examined contained a data availability statement
(n = 159 (42.0%)). This lack of availability statement at publication results in a loss of useful
information. For at least one published article, we identified relevant information in the pre-
printed statement that did not appear anywhere in the published article, due to it not contain-
ing a data availability statement [48, 49].
We provide initial descriptive evidence that strict data-sharing policies, which mandate that
data be made openly available (where appropriate) as a condition of publication, appear to suc-
ceed in making research data more open than those that do not. Our findings, though based
on a relatively small number of observations, agree with other studies on the effect of journal
policies on author behavior. Recent work has shown that “requiring” a data availability state-
ment was effective in ensuring that this element was completed [4], while “encouraging”
authors to follow a reporting checklist (the ARRIVE checklist) had no effect on compliance
[50, 51].
Finally, we also provide evidence that data availability statements alone are insufficient to
capture code availability declarations. Even when researchers wish to share their code, as evi-
denced by a description of code availability in the main paper, they frequently do not include
this information in the data availability statement. Code sharing has been advocated strongly
elsewhere [52–54], as it provides an insight into the analytic decisions made by the research
team, and there are few, if any, circumstances in which it is not possible to share the analytic
code underpinning an analysis. Similar to data availability statements, a dedicated code avail-
ability statement which is critically assessed against a clear code-sharing policy as part of the
editorial and peer review processes will help researchers to appraise published results.
4.2 Strengths and limitations
A particular strength of this analysis is that the design allows us to compare what is essentially
the same paper (same design, findings and authorship team) under two different data-sharing
polices, and assess the change in the openness of the statement between them. To our knowl-
edge this is the first study to use this approach to examine the potential impact of journal edito-
rial policies. This approach also allows us to address the issue of self-selection. When looking
at published articles alone, it is not possible to tell whether authors always intended to make
their data available and chose a given journal due to its reputation for data sharing. In addition,
we have examined all available preprints within our study period and all corresponding pub-
lished articles, rather than taking a sub-sample. Finally, categorization of the statements was
carried out by two independent researchers using predefined categories, reducing the risk of
misclassification.
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However, our analysis is subject to a number of potential limitations. The primary one is
that manuscripts (at both the preprint and published stages) may have included links to the
data, or more information that uniquely identifies the dataset from a data portal, within the
text (for example, in the Methods section). While this might be the case, if readers are expected
to piece together the relevant information from different locations in the manuscript, it throws
into question what having a dedicated data availability statement adds. A second limitation is
that we do not assess the veracity of any data availability statements, which may introduce
some misclassification bias into our categorization. For example, we do not check whether all
relevant data can actually be found in the manuscript/S1 File (Category 7) or the linked reposi-
tory (Category 8), meaning our results provide a conservative estimate of the scale of the issue,
asprevious work has suggested that this is unlikely to be the case [12]. A further consideration
is that for Categories 1 (“No data available”) and 2 (“Available on request”), there will be situa-
tions where making research data available is not feasible, for example, due to cost or concerns
about patient re-identifiability [55, 56]. This situation is perfectly reasonable, as long as state-
ments are explicit in justifying the lack of open data.
4.3 Implications for policy
Data availability statements are an important tool in the fight to make studies more reproduc-
ible. However, without critical review of these statements in line with strict data-sharing poli-
cies, authors default to not sharing their data or making it “available on request”. Based on our
analysis, there is a greater change towards describing open data between preprinted and pub-
lished data availability statements in journals that mandate data sharing as a condition of pub-
lication. This would suggest that data sharing could be immediately improved by journals
becoming more stringent in their data availability policies. Similarly, introduction of a related
code availability section (or composite “material” availability section) will aid in reproducibil-
ity by capturing whether analytic code is available in a standardized manuscript section.
It would be unfair to expect all editors and reviewers to be able to effectively review the
code and data provided with a submission. As proposed elsewhere [57], a possible solution is
to assign an editor or reviewer whose sole responsibility in the review process is to examine the
data and code provided. They would also be responsible for judging, when data and code are
absent, whether the argument presented by the authors for not sharing these materials is valid.
However, while this study focuses primarily on the role of journals, some responsibility for
enacting change rests with the research community at large. If researchers regularly shared our
data, strict journal data-sharing policies would not be needed. As such, we would encourage
authors to consider sharing the data underlying future publications, regardless of whether the
journal actually mandates it.
5 Conclusion
Requiring that authors submit a data availability statement is a good first step, but is insuffi-
cient to ensure data availability, as our work shows that authors most commonly use them to
state that data is only available on request. However, strict editorial policies that mandate data
sharing (where appropriate) as a condition of publication appear to be effective in making
research data available. In addition to the introduction of a dedicated code availability state-
ment, a move towards mandated data sharing will help to ensure that future research is readily
reproducible. We would strongly encourage all journal editors to examine whether their data
availability policies are sufficiently stringent and consistently enforced.
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